Variant report
Variant | esv3462338 |
---|---|
Chromosome Location | chr3:110678659-110679165 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs375616480 | chr3:110678675-110678676 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs35665971 | chr3:110678676-110678677 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs543583996 | chr3:110678677-110678678 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs75920939 | chr3:110678682-110678683 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs531824332 | chr3:110678715-110678716 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs184480814 | chr3:110678738-110678739 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs66513024 | chr3:110678768-110678769 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs569651277 | chr3:110678781-110678782 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs527991643 | chr3:110678793-110678794 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs67056469 | chr3:110678833-110678834 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs141765185 | chr3:110678849-110678850 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs536491268 | chr3:110678855-110678856 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs571867892 | chr3:110678883-110678884 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs113944576 | chr3:110678895-110678896 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs569661363 | chr3:110678928-110678929 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs538691740 | chr3:110678947-110678948 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs145421762 | chr3:110678957-110678958 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs551849768 | chr3:110678998-110678999 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs374558656 | chr3:110679011-110679012 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs190536171 | chr3:110679012-110679013 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs192676325 | chr3:110679015-110679016 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs182495318 | chr3:110679018-110679019 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs574674300 | chr3:110679019-110679020 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs184507825 | chr3:110679061-110679062 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs563449327 | chr3:110679064-110679065 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs531732386 | chr3:110679105-110679106 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Cervical cancer | 21062161 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Breast cancer | 22032731 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
microdeletion syndrome | 22180640 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 16608533 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Developmental delay | 22180640 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Multiple myeloma | 17550852 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:110670400-110682400 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
2 | chr3:110674800-110684600 | Weak transcription | ES-WA7 Cell Line | embryonic stem cell |
3 | chr3:110678800-110680600 | Enhancers | Dnd41 | blood |